Prognostic Significance of Epithelial Cells in the Blood of Patients with Gynaecological Malignancies

Anticancer Research

Volumn 23, Issue 5 B, 2003, Pages 4133-4140

  Sehouli, Jalid ^a   Könsgen, Dominique ^a   Nimpsch, Robert ^a   Stengel, Dirk ^b   Oskay, Gülten ^a   Mustea, Alexander ^a   Oertel, Joachim ^a   Lichtenegger, Werner ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Emergency Hospital Berlin   (Germany)

Author keywords

Cytokeratin; Epithelial cells; Gynaecologic cancer

Indexed keywords

CYTOKERATIN; KERATIN ANTIBODY;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BLOOD; BLOOD SAMPLING; BREAST CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM CANCER; EPITHELIUM CELL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; UTERINE CERVIX CANCER; VULVA CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; EPITHELIAL CELLS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0344530788     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Parker SL, Tong T, Bolden S and Wingo PA: Cancer statistics. CA Cancer J Clin 46(1): 3-4, 1996.
2. Landis SH, Murray T and Bolden S et al: Cancer statistics, 1999, CA Cancer J Clin 49: 8-31, 1999
3. Bundred NJ: Prognostic and predictive factors in breast cancer. Review. Cancer Treat Rev 27(3): 137-42, 2001.
4. www.uicc.org/programmes/detection/tnm.
5. Illiger HJ: Der monoklonale Antikörper17-1A. Internist 38: 1001-06, 1997.
6. Diel IJ: Metaanalyse zur prognostischen bedeutung des tumorzellnachweises im knochenmark oder "auf der suche nach dem unabhängigen prognosefaktor". Strahlenther Onkol 175: 44-6, 1999.
7. Oruzio D and Hempel D et al: Knochenmarkmikrometastasen epithelialer tumoren, nachweis und klinische bedeutung. Onkologe 3: 66-72, 1997.
8. Lambrechts AC, van't Veer LJ and Rodenhuis S: The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: use, limitations and future of RNA-based methods. Ann Oncol 9(12): 1269-76, 1998.
9. Janni W, Gastroph S, Hepp F, Kentenich C, Rjosk D, Schindlbeck C, Dimpfl T, Sommer H and Braun S: Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma. Cancer 15, 88(10): 2252-9, 2000.
10. Harbeck N et al: Tumor cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer 69: 566-71, 1994.
11. Marth C, Trope C and Hofeldt H et al: Carcinoma cells in bone marrow and peripheral blood of ovarian cancer patients. The Norwegian Radiumhospital Oslo, Norway; (Poster)-Onkolog. Kongress, Berlin-Charité, 1998.
12. Zhong XY, Kaul S, Eichler A and Bastert G: Low specificity of MUC1 as a marker to detect epithelial cancer dissemination in human bone marrow and blood. Clin Lab 44: 971-978, 1998.
13. Slovin SF and Scher HI: Detectable tumor cells in the blood and bone marrow; smoke or fire? Cancer August 1(83), Nr. 3; 394-398, 1998.
14. Smith BM, Slade MJ, English J and Graham H et al: Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction an immunocytochemical techniques. J Clin Oncol 18(7): 1432-9, 2000.
15. Pantel K, Schlimok G and Angstwurm M et al: Methodological analysis of immunocytochemical screening for disseminated epithelial tumour cells in bone marrow. J Hematother 3: 165-173, 1994.
16. Funke I et al: Metaanalysis of studies on bone marrow micrometastases: an indepent prognostic impact remains to be substantiated. J Clin Oncol 16: 557-66, 1998.
17. Hepp F, Kentenich CRM, Janni W and Braun S: Clinical value of screening (CK)-positive bone marrow micrometastases in stage I-II cervical cancer. Eur J Cancer 35(4): 230, 1999.
18. Oberhoff C and Kasimir-Bauer S et al: Detection of isolated tumor cells in the bone marrow of patients with primary breast cancer. Immunomagnet. separation and Immunocytochemistry. Proceedings of ASCO, Abstract 462, 34th ASCO Annual Meeting.
19. Braun S, Cevatli BS, Assemi C, Janni W, Kentenich Ch, Schindlbeck Ch, Rjosk D and Hepp F: Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy. JCO Mar 1: 1468-1475, 2001.
20. Gebauer et al: Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up. J Clin Oncol, in press.
21. Mansi JL et al: The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 7(4): 445-449, 1998.
22. Mansi et al: The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence. Cancer. 2001, Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study. Lancet 17: 354: 197-202, 1999.
23. Mansi et al: The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence. Cancer. 2001, Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study. Lancet 17: 354: 197-202, 1999.
24. Berger U, Bettelheim R and Mansi JL et al: The relationsship between micro-metastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J Clin Pathol 90: 1-6, 1998.
25. Dearnaley DP, Ormerod MG and Sloane JP: Micrometastases in breast cancer: long-term follow-up of the first patient cohort. Eur J Cancer 27(3): 236-9, 1991.
26. Denis MG, Lipart C, Leborgne J, LeHur PA, Galmiche JP, Denis M, Ruud E, Truchaud A and Lustenberger P: Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer Oct 21 74(5): 540-4, 1997.
27. Hardingham JE, Kotasek D, Sage RE, Eaton MC, Pascoe VH and Dobrovic A: Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease. Mol Med. Nov 1(7): 789-94; 1995.
28. Yeh KH, Chen YC, Yeh SH, Chen CP, Lin JT and Cheng AL: Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19)-possible clinical significance in advanced gastric cancer. Anticancer Res 18(2B): 1283-6, 1998.
29. Kim SJ, Ikeda N, Shiba E, Takamura Y and Noguchi S: Detection of breast cancer micrometastases in peripheral blood using immunomagnetic separation and immunocytochemistry. Breast Cancer 8(1): 63-9, 2001.
30. Pecorelli S et al: FIGO Annual report on the results of treatment in gynecologi cancer. FIGO Committee on Gynecologic Oncology. J Epidemiol Biostat 24: 2001.